Contains fulltext : 52836.pdf (Publisher’s version ) (Open Access)OBJECTIVE: To compare the effects of alendronate and alfacalcidol in the prevention ofglucocorticoid-related osteoporosis in patients with a rheumatic disease.
Laan, R.F.J.M. +12 more
core
Alfacalcidol plus calcium versus cholecalciferol in glucocorticoid-exposed children with nephrotic syndrome: a randomized controlled trial. [PDF]
Chen HR +9 more
europepmc +1 more source
Site-Specific Responses to SERM Treatment in Postmenopausal Osteoporosis: No Clear Age Attenuation in a Real-World Study. [PDF]
Nagai T +8 more
europepmc +1 more source
Prior treatment, not vitamin D, predicts romosozumab response in 314 osteoporosis patients: A retrospective cohort study. [PDF]
Nakano R +4 more
europepmc +1 more source
Reply to Çevik et al. Comment on "Inghilleri, G.; Franchini, M. Hypophosphatemia in Patients Receiving Intravenous Iron Supplementation for Iron-Deficiency Anemia: A Narrative Review. <i>J. Clin. Med.</i> 2026, <i>15</i>, 4748". [PDF]
Inghilleri G, Franchini M.
europepmc +1 more source
Gastric mucosal calcinosis: abnormal calcium deposition in a haemodialysis patient. [PDF]
Jones RT, Bingham C, Rogers J, Huish S.
europepmc +1 more source
A Case of Severe Hypercalcemia in a Patient Taking Tirzepatide: Potential Risk Factors. [PDF]
Iqbal S, Javed F, Oyibo SO.
europepmc +1 more source
Teriparatide for the treatment of primary hypoparathyroidism in children. [PDF]
Huang S, Song F.
europepmc +1 more source
Effect of active vitamin D supplementation on muscle mass and function in peritoneal dialysis patients with sarcopenia: a randomized controlled trial. [PDF]
Wang L, Zhu B, Xue C, Zhou F, Luo Q.
europepmc +1 more source

